FXYD-3 expression in relation to local recurrence of rectal cancer
Per Loftas, Gunnar Arbman, Xiao-Feng Sun, David Edler, Erik Syk, Olof Hallbook
Radiat Oncol J. 2016;34(1):52-58.   Published online 2016 Mar 30     DOI: https://doi.org/10.3857/roj.2016.34.1.52
Citations to this article as recorded by Crossref logo
The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations
Eryong Zhao, Kefei Gao, Jian Xiong, Zhihong Liu, Yuelin Chen, Lisha Yi
Journal of Cancer Research and Clinical Oncology.2023; 149(19): 17269.     CrossRef
FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
Satoru Yonekura, Kosuke Ueda
Cancers.2022; 14(15): 3596.     CrossRef
Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116
Jae Kyung Myung, Seung-Gu Yeo, Kyung Hee Kim, Kwang-Soo Baek, Daye Shin, Jong Heon Kim, Jae Youl Cho, Byong Chul Yoo
Oncotarget.2017; 8(4): 6819.     CrossRef
Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer
Kangsan Roh, Seung-Gu Yeo, Byong Chul Yoo, Kyung-Hee Kim, Sun Young Kim, Min-Jeong Kim
Anti-Cancer Drugs.2016; 27(8): 787.     CrossRef
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy
Jeong Il Yu, Hyebin Lee, Hee Chul Park, Doo Ho Choi, Yoon-La Choi, In-Gu Do, Hee Cheol Kim, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Young Suk Park, Joon Oh Park, Seung Tae Kim, Won Park
Oncotarget.2016; 7(38): 62676.     CrossRef